Enzo Biochem, Inc.
ENZB
$0.5299
-$0.01-1.85%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -81.76% | 54.53% | 74.77% | -343.08% | 1.34% |
| Total Depreciation and Amortization | 0.00% | -0.31% | -19.85% | 18.10% | 26.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -209.55% | 15.28% | -87.14% | 177.39% | 422.22% |
| Change in Net Operating Assets | 85.93% | 79.27% | -175.58% | 691.80% | 75.23% |
| Cash from Operations | -58.93% | 77.46% | -728.57% | 62.09% | 67.98% |
| Capital Expenditure | -451.43% | 84.38% | -264.23% | 13.99% | -472.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -- | -- | -- |
| Cash from Investing | -451.43% | -101.54% | 3,800.81% | 13.99% | -472.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 98.97% | -9,654.05% | -68.18% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 100.00% | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 100.00% | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 99.21% | -2,562.00% | 94.46% | -8,102.27% | -100.00% |
| Foreign Exchange rate Adjustments | 344.44% | -1,000.00% | -93.75% | 188.89% | -289.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 51.55% | -60.44% | 3.11% | -55.11% | 65.59% |